Literature DB >> 20944497

Misidentification of Candida parapsilosis as C famata in a clinical case of vertebral osteomyelitis.

Mary Jane Burton1, Pratik Shah, Edwin Swiatlo.   

Abstract

A case of vertebral osteomyelitis involving misidentification of Candida parapsilosis as C famata by the VITEK 2 compact is described. Species-specific primers were used in the polymerase chain reaction to correctly identify the clinical isolate. When uncommon species of Candida are reported using automated systems, heightened clinical suspicion is warranted.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20944497     DOI： 10.1097/MAJ.0b013e3181f54dab

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


  7 in total

1.  Reliability of automated biochemical identification of Burkholderia pseudomallei is regionally dependent.

Authors:  Yuwana Podin; Mirjam Kaestli; Nicole McMahon; Jann Hennessy; Hie Ung Ngian; Jin Shyan Wong; Anand Mohana; See Chang Wong; Timothy William; Mark Mayo; Robert W Baird; Bart J Currie
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

2.  Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolates.

Authors:  Joseph Meletiadis; Michael Arabatzis; Maria Bompola; Konstantinos Tsiveriotis; Stavroula Hini; Efthymia Petinaki; Aristea Velegraki; Loukia Zerva
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

3.  Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011).

Authors:  Maria N Gamaletsou; Dimitrios P Kontoyiannis; Nikolaos V Sipsas; Brad Moriyama; Elizabeth Alexander; Emmanuel Roilides; Barry Brause; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-08-21       Impact factor: 9.079

4.  Misidentification of a Rare Species, Cryptococcus laurentii, by Commonly Used Commercial Biochemical Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Systems: Challenges for Clinical Mycology Laboratories.

Authors:  Meng Xiao; Xin Fan; Xin-Xin Chen; He Wang; Li Zhang; Zhi-Peng Xu; Timothy Kudinha; Fanrong Kong; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2015-11-11       Impact factor: 5.948

5.  Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance programme.

Authors:  Michael A Pfaller; Leah N Woosley; Shawn A Messer; Ronald N Jones; Mariana Castanheira
Journal:  Mycopathologia       Date:  2012-05-13       Impact factor: 2.574

6.  Molecular identification of Pichia guilliermondii, Debaryomyces hansenii and Candida palmioleophila.

Authors:  Adolfo Jose Mota; Graziella Nuernberg Back-Brito; Francisco G Nobrega
Journal:  Genet Mol Biol       Date:  2011-12-15       Impact factor: 1.771

7.  Misidentification of Candida guilliermondii as C. famata among strains isolated from blood cultures by the VITEK 2 system.

Authors:  Si Hyun Kim; Jeong Hwan Shin; Jeong Ha Mok; Shine Young Kim; Sae Am Song; Hye Ran Kim; Joong-Ki Kook; Young-Hyo Chang; Il Kwon Bae; Kwangha Lee
Journal:  Biomed Res Int       Date:  2014-05-29       Impact factor: 3.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.